HB 1721

  • Illinois House Bill
  • 102nd Regular Session
  • Introduced in House
  • House
  • Senate
  • Governor

Pharmaceutical Ingredients

Abstract

Amends the Illinois Food, Drug and Cosmetic Act. Requires a manufacturer of a prescription drug that is sold, offered for sale, or distributed in this State, or placed on a formulary to be eligible for payment, co-payment, or reimbursement in this State, to notify the Department of Public Health of specified information concerning active pharmaceutical ingredients.

Bill Sponsors (5)

Votes


No votes to display

Actions


Jan 10, 2023

House

Session Sine Die

Apr 23, 2021

House

Rule 19(a) / Re-referred to Rules Committee

Apr 14, 2021

House

Second Reading - Consent Calendar

House

Held on Calendar Order of Second Reading - Consent Calendar

House

Added Co-Sponsor Rep. Ryan Spain

House

Added Co-Sponsor Rep. La Shawn K. Ford

House

Removed from Consent Calendar Status Rep. Greg Harris

House

Held on Calendar Order of Second Reading - Short Debate

Apr 06, 2021

House

Added Chief Co-Sponsor Rep. Carol Ammons

Mar 18, 2021

House

Placed on Calendar 2nd Reading - Consent Calendar

Mar 15, 2021

House

Do Pass / Consent Calendar Consumer Protection Committee; 006-000-000

Mar 09, 2021

House

Added Co-Sponsor Rep. Jonathan Carroll

House

Assigned to Consumer Protection Committee

Feb 17, 2021

House

Referred to Rules Committee

House

First Reading

Feb 11, 2021

House

Filed with the Clerk by Rep. Deanne M. Mazzochi

Bill Text

Bill Text Versions Format
Introduced HTML PDF

Related Documents

Document Format
No related documents.

Sources

Data on Open States is updated periodically throughout the day from the official website of the Illinois General Assembly.

If you notice any inconsistencies with these official sources, feel free to file an issue.